6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine

C136H188N42O7S3 — CID 159508344

IUPAC6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine
SMILESCC(C)c1cn2nc(-n3ccnc3)ccc2n1.CC(C)c1cn2nc(C3CC3)ccc2n1.CC(C)c1cn2nc(N3CCCC3)ccc2n1.CC(C)c1cn2nc(N3CCOCC3)ccc2n1.CC(C)c1cn2ncccc2n1.CC(C)c1nnc2n1CC(S(C)(=O)=O)CC2.CC(C)c1nnc2n1CCN(C)C2.CC(C)c1nnc2n1CCN(S(C)(=O)=O)C2.CC(C)c1nnc2n1CN(C)CC2.CC(C)c1onc2ccccc12.CC(C)c1snc2ccccc12.COc1ccc2nc(C(C)C)cn2n1.Cc1ccc2nc(C(C)C)cn2n1
InChIInChI=1S/C13H18N4O.C13H18N4.C12H13N5.C12H15N3.C10H17N3O2S.C10H13N3O.C10H13N3.C10H11NO.C10H11NS.C9H16N4O2S.2C9H16N4.C9H11N3/c1-10(2)11-9-17-12(14-11)3-4-13(15-17)16-5-7-18-8-6-16;1-10(2)11-9-17-12(14-11)5-6-13(15-17)16-7-3-4-8-16;1-9(2)10-7-17-11(14-10)3-4-12(15-17)16-6-5-13-8-16;1-8(2)11-7-15-12(13-11)6-5-10(14-15)9-3-4-9;1-7(2)10-12-11-9-5-4-8(6-13(9)10)16(3,14)15;1-7(2)8-6-13-9(11-8)4-5-10(12-13)14-3;1-7(2)9-6-13-10(11-9)5-4-8(3)12-13;2*1-7(2)10-8-5-3-4-6-9(8)11-12-10;1-7(2)9-11-10-8-6-12(16(3,14)15)4-5-13(8)9;1-7(2)9-11-10-8-6-12(3)4-5-13(8)9;1-7(2)9-11-10-8-4-5-12(3)6-13(8)9;1-7(2)8-6-12-9(11-8)4-3-5-10-12/h3-4,9-10H,5-8H2,1-2H3;5-6,9-10H,3-4,7-8H2,1-2H3;3-9H,1-2H3;5-9H,3-4H2,1-2H3;7-8H,4-6H2,1-3H3;4-7H,1-3H3;4-7H,1-3H3;2*3-7H,1-2H3;7H,4-6H2,1-3H3;2*7H,4-6H2,1-3H3;3-7H,1-2H3
InChIKeyMAGZCNWINNZKEF-UHFFFAOYSA-N
MW2619.49 g/mol
LogP23.79
Rot. Bonds20

About 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine

6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine (PubChem CID 159508344) has the molecular formula C136H188N42O7S3 and a molecular weight of 2619.49 g/mol. Its IUPAC name is 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine.

Molecular Properties

Compound Name6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine
PubChem CID159508344
Molecular FormulaC136H188N42O7S3
Molecular Weight2619.49 g/mol
Exact Mass2617.48
IUPAC Name6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine
SMILESCC(C)c1cn2nc(-n3ccnc3)ccc2n1.CC(C)c1cn2nc(C3CC3)ccc2n1.CC(C)c1cn2nc(N3CCCC3)ccc2n1.CC(C)c1cn2nc(N3CCOCC3)ccc2n1.CC(C)c1cn2ncccc2n1.CC(C)c1nnc2n1CC(S(C)(=O)=O)CC2.CC(C)c1nnc2n1CCN(C)C2.CC(C)c1nnc2n1CCN(S(C)(=O)=O)C2.CC(C)c1nnc2n1CN(C)CC2.CC(C)c1onc2ccccc12.CC(C)c1snc2ccccc12.COc1ccc2nc(C(C)C)cn2n1.Cc1ccc2nc(C(C)C)cn2n1
InChIInChI=1S/C13H18N4O.C13H18N4.C12H13N5.C12H15N3.C10H17N3O2S.C10H13N3O.C10H13N3.C10H11NO.C10H11NS.C9H16N4O2S.2C9H16N4.C9H11N3/c1-10(2)11-9-17-12(14-11)3-4-13(15-17)16-5-7-18-8-6-16;1-10(2)11-9-17-12(14-11)5-6-13(15-17)16-7-3-4-8-16;1-9(2)10-7-17-11(14-10)3-4-12(15-17)16-6-5-13-8-16;1-8(2)11-7-15-12(13-11)6-5-10(14-15)9-3-4-9;1-7(2)10-12-11-9-5-4-8(6-13(9)10)16(3,14)15;1-7(2)8-6-13-9(11-8)4-5-10(12-13)14-3;1-7(2)9-6-13-10(11-9)5-4-8(3)12-13;2*1-7(2)10-8-5-3-4-6-9(8)11-12-10;1-7(2)9-11-10-8-6-12(16(3,14)15)4-5-13(8)9;1-7(2)9-11-10-8-6-12(3)4-5-13(8)9;1-7(2)9-11-10-8-4-5-12(3)6-13(8)9;1-7(2)8-6-12-9(11-8)4-3-5-10-12/h3-4,9-10H,5-8H2,1-2H3;5-6,9-10H,3-4,7-8H2,1-2H3;3-9H,1-2H3;5-9H,3-4H2,1-2H3;7-8H,4-6H2,1-3H3;4-7H,1-3H3;4-7H,1-3H3;2*3-7H,1-2H3;7H,4-6H2,1-3H3;2*7H,4-6H2,1-3H3;3-7H,1-2H3
InChIKeyMAGZCNWINNZKEF-UHFFFAOYSA-N
XLogP23.79
TPSA493.85 Ų
H-Bond Donors
H-Bond Acceptors49
Rotatable Bonds20
Heavy Atoms188
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002619.49
LogP ≤ 523.79
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1049

Analyze 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine?
The IUPAC name of 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine (CID 159508344) is 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine.
What is the SMILES notation for 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine?
The canonical SMILES for 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine is CC(C)c1cn2nc(-n3ccnc3)ccc2n1.CC(C)c1cn2nc(C3CC3)ccc2n1.CC(C)c1cn2nc(N3CCCC3)ccc2n1.CC(C)c1cn2nc(N3CCOCC3)ccc2n1.CC(C)c1cn2ncccc2n1.CC(C)c1nnc2n1CC(S(C)(=O)=O)CC2.CC(C)c1nnc2n1CCN(C)C2.CC(C)c1nnc2n1CCN(S(C)(=O)=O)C2.CC(C)c1nnc2n1CN(C)CC2.CC(C)c1onc2ccccc12.CC(C)c1snc2ccccc12.COc1ccc2nc(C(C)C)cn2n1.Cc1ccc2nc(C(C)C)cn2n1.
What is the InChIKey of 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine?
The InChIKey is MAGZCNWINNZKEF-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H18N4O.C13H18N4.C12H13N5.C12H15N3.C10H17N3O2S.C10H13N3O.C10H13N3.C10H11NO.C10H11NS.C9H16N4O2S.2C9H16N4.C9H11N3/c1-10(2)11-9-17-12(14-11)3-4-13(15-17)16-5-7-18-8-6-16;1-10(2)11-9-17-12(14-11)5-6-13(15-17)16-7-3-4-8-16;1-9(2)10-7-17-11(14-10)3-4-12(15-17)16-6-5-13-8-16;1-8(2)11-7-15-12(13-11)6-5-10(14-15)9-3-4-9;1-7(2)10-12-11-9-5-4-8(6-13(9)10)16(3,14)15;1-7(2)8-6-13-9(11-8)4-5-10(12-13)14-3;1-7(2)9-6-13-10(11-9)5-4-8(3)12-13;2*1-7(2)10-8-5-3-4-6-9(8)11-12-10;1-7(2)9-11-10-8-6-12(16(3,14)15)4-5-13(8)9;1-7(2)9-11-10-8-6-12(3)4-5-13(8)9;1-7(2)9-11-10-8-4-5-12(3)6-13(8)9;1-7(2)8-6-12-9(11-8)4-3-5-10-12/h3-4,9-10H,5-8H2,1-2H3;5-6,9-10H,3-4,7-8H2,1-2H3;3-9H,1-2H3;5-9H,3-4H2,1-2H3;7-8H,4-6H2,1-3H3;4-7H,1-3H3;4-7H,1-3H3;2*3-7H,1-2H3;7H,4-6H2,1-3H3;2*7H,4-6H2,1-3H3;3-7H,1-2H3.
What are the key properties of 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine?
6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine has a molecular weight of 2619.49 g/mol, XLogP of 23.79, 20 rotatable bonds, 0 hydrogen bond donors, and 49 hydrogen bond acceptors.
Where does this data come from?
All data for 6-cyclopropyl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-imidazol-1-yl-2-propan-2-ylimidazo[1,2-b]pyridazine;6-methoxy-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methyl-3-propan-2-yl-7,8-dihydro-5H-[1,2,4]triazolo[4,3-c]pyrimidine;6-methyl-2-propan-2-ylimidazo[1,2-b]pyridazine;7-methylsulfonyl-3-propan-2-yl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;6-methylsulfonyl-3-propan-2-yl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;3-propan-2-yl-2,1-benzothiazole;3-propan-2-yl-2,1-benzoxazole;2-propan-2-ylimidazo[1,2-b]pyridazine;4-(2-propan-2-ylimidazo[1,2-b]pyridazin-6-yl)morpholine;2-propan-2-yl-6-pyrrolidin-1-ylimidazo[1,2-b]pyridazine is sourced from PubChem (CID 159508344), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).